{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T08:04:54Z","timestamp":1791360294513,"version":"4.3.1"},"reference-count":67,"publisher":"Deutscher Arzte-Verlag GmbH","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.3238\/arztebl.2016.0011","type":"journal-article","created":{"date-parts":[[2018,5,2]],"date-time":"2018-05-02T09:27:14Z","timestamp":1525253234000},"source":"Crossref","is-referenced-by-count":35,"title":["The Presentation, Diagnosis, and Treatment of Sexually Transmitted Infections"],"prefix":"10.3238","author":[{"given":"Florian M.E.","family":"Wagenlehner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norbert H.","family":"Brockmeyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Discher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Friese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas A.","family":"Wichelhaus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"11437","published-online":{"date-parts":[[2016,1,11]]},"reference":[{"key":"10.3238\/arztebl.2016.0011_ref1","unstructured":"WHO: Sexually transmitted infections (STIs) 2013. Fact Sheet N. 110. www.who.int\/mediacentre\/factsheets\/fs110\/en\/ (last accessed on 10 November 2015)."},{"key":"10.3238\/arztebl.2016.0011_ref2","unstructured":"Robert Koch-Institut: Sechs Jahre STD-Sentinel Surveillance in Deutschland \u2013 Zahlen und Fakten. Epidemiologisches Bulletin 2010; 3: 20\u201327."},{"key":"10.3238\/arztebl.2016.0011_ref3","doi-asserted-by":"crossref","unstructured":"Hokororo A, Kihunrwa A, Hoekstra P, et al.: High prevalence of sexually transmitted infections in pregnant adolescent girls in Tanzania: a multi-community cross-sectional study. Sex Transm Infect 2015; 91: 473\u20138","DOI":"10.1136\/sextrans-2014-051952"},{"key":"10.3238\/arztebl.2016.0011_ref4","doi-asserted-by":"crossref","unstructured":"Kissinger P: Trichomonas vaginalis: a review of epidemiologic, clinical and treatment issues. BMC Infect Dis 2015; 15: 307","DOI":"10.1186\/s12879-015-1055-0"},{"key":"10.3238\/arztebl.2016.0011_ref5","unstructured":"Bremer V, Brockmeyer N, Coenenberg J, et al.: Leitlinie STI\/STD\u2013 Beratung, Diagnostik und Therapie. In: AWMF, 2014. (last accessed on 10 December 2015)."},{"key":"10.3238\/arztebl.2016.0011_ref6","unstructured":"Workowski KA, Bolan G: Sexually transmitted diseases treatment guidelines, 2014. In: Control CfD, editor.; 2014."},{"key":"10.3238\/arztebl.2016.0011_ref7","unstructured":"Bremer V, Brockmeyer NH, Esser S, et al.: Leitlinie Diagnostik und Therapie der Syphilis, Aktualisierung und Aufwertung S2k2014. In: AWMF; 2014. www.awmf.org\/uploads\/tx_szleitlinien\/059\u2013002l_S2k_Diagnostik_Therapie_Syphilis_2014_07.pdf (last accessed on 10 December 2015)."},{"key":"10.3238\/arztebl.2016.0011_ref8","unstructured":"Beckmann M, Wojcinski M, Weissenbacher ER, et al: Leitlinie Pr\u00e4vention, Diagnostik und Therapie der HPV-Infektion und pr\u00e4invasiver L\u00e4sionen des weiblichen Genitale. In: AWMF; 2010. www.awmf.org\/uploads\/tx_szleitlinien\/015\u2013027_S2_IDA_Praevention_Diagnostik_und_Therapie_der_HPV-Infektion_und_praeinvasiver_Laesionen_des_weiblichen_Genitale_abgelaufen.pdf (last accessed on 10 December 2015)."},{"key":"10.3238\/arztebl.2016.0011_ref9","unstructured":"Bremer V, Brockmeyer N, Buder, S, et al.: Gonorrhoe bei Erwachsenen und Adoleszenten. In: AWMF, 2013. www.awmf.org\/uploads\/tx_szleitlinien\/059\u2013004l_S25_Gonorrhoe_bei_Erwachsenen_Adoleszenten_2014-verlaengert.pdf (last accessed on 10 December 2015)."},{"key":"10.3238\/arztebl.2016.0011_ref10","unstructured":"Abele-Horn M, Blenk H, Clad A, et al.: Genitalinfektionen Teil I: Infektionen des weiblichen und des m\u00e4nnlichen Genitaltraktes. M\u00fcnchen: Urban & Fischer 2011."},{"key":"10.3238\/arztebl.2016.0011_ref11","unstructured":"Abele-Horn M, Blenk H, Clad A,et al: Genitalinfektionen Teil II. Infektionserreger: Bakterien. M\u00fcnchen: Urban & Fischer; 2011."},{"key":"10.3238\/arztebl.2016.0011_ref12","unstructured":"Abele-Horn M, Blenk H, Clad A, et al.: Genitalinfektionen Teil II. Infektionserreger: Parasiten, Viren. M\u00fcnchen: Urban & Fischer; 2011."},{"key":"10.3238\/arztebl.2016.0011_ref13","doi-asserted-by":"crossref","unstructured":"Le Cleach L, Trinquart L, Do G, et al.: Oral antiviral therapy for prevention of genital herpes outbreaks in immunocompetent and nonpregnant patients. Cochrane Database Syst Rev 2014; 8: CD009036","DOI":"10.1002\/14651858.CD009036.pub2"},{"key":"10.3238\/arztebl.2016.0011_ref14","doi-asserted-by":"crossref","unstructured":"Williams JR, Jordan JC, Davis EA, Garnett GP: Suppressive valacyclovir therapy: impact on the population spread of HSV-2 infection. Sex Transm Dis 2007; 34: 123\u201331","DOI":"10.1097\/01.olq.0000258486.81492.a2"},{"key":"10.3238\/arztebl.2016.0011_ref15","doi-asserted-by":"crossref","unstructured":"Bartelsman M, Straetemans M, Vaughan K, et al.: Comparison of two Gram stain point-of-care systems for urogenital gonorrhoea among high-risk patients: diagnostic accuracy and cost-effectiveness before and after changing the screening algorithm at an STI clinic in Amsterdam. Sex Transm Infect 2014; 90: 358\u201362","DOI":"10.1136\/sextrans-2013-051500"},{"key":"10.3238\/arztebl.2016.0011_ref16","doi-asserted-by":"crossref","unstructured":"Lewis DA: Global resistance of Neisseria gonorrhoeae: when theory becomes reality. Curr Opin Infect Dis 2014; 27: 62\u20137","DOI":"10.1097\/QCO.0000000000000025"},{"key":"10.3238\/arztebl.2016.0011_ref17","doi-asserted-by":"crossref","unstructured":"Ndowa F, Lusti-Narasimhan M, Unemo M: The serious threat of multidrug-resistant and untreatable gonorrhoea: the pressing need for global action to control the spread of antimicrobial resistance, and mitigate the impact on sexual and reproductive health. Sex Transm Infect 2012; 88: 317\u20138","DOI":"10.1136\/sextrans-2012-050674"},{"key":"10.3238\/arztebl.2016.0011_ref18","doi-asserted-by":"crossref","unstructured":"Unemo M, Nicholas RA: Emergence of multidrug-resistant, extensively drug-resistant and untreatable gonorrhea. Future Microbiol 2012; 7: 1401\u201322","DOI":"10.2217\/fmb.12.117"},{"key":"10.3238\/arztebl.2016.0011_ref19","doi-asserted-by":"crossref","unstructured":"Horn NN, Kresken M, Korber-Irrgang B, et al. Antimicrobial susceptibility and molecular epidemiology of Neisseria gonorrhoeae in Germany. Int J Med Microbiol 2014; 304: 586\u201391","DOI":"10.1016\/j.ijmm.2014.04.001"},{"key":"10.3238\/arztebl.2016.0011_ref20","doi-asserted-by":"crossref","unstructured":"Horner P, Blee K, Adams E: Time to manage mycoplasma genitalium as an STI: but not with azithromycin 1 g! Curr Opin Infect Dis 2014; 27: 68\u201374","DOI":"10.1097\/QCO.0000000000000030"},{"key":"10.3238\/arztebl.2016.0011_ref21","doi-asserted-by":"crossref","unstructured":"Cook RL, Hutchison SL, Ostergaard L, Braithwaite RS, Ness RB: Systematic review: noninvasive testing for Chlamydia trachomatis and Neisseria gonorrhoeae. Ann Intern Med 2005; 142: 914\u201325","DOI":"10.7326\/0003-4819-142-11-200506070-00010"},{"key":"10.3238\/arztebl.2016.0011_ref22","unstructured":"Yanofsky VR, Patel RV, Goldenberg G: Genital warts: a comprehensive review. J Clin Aesthet Dermatol 2012; 5: 25\u201336 MEDLINE"},{"key":"10.3238\/arztebl.2016.0011_ref23","doi-asserted-by":"crossref","unstructured":"Roth AM, Williams JA, Ly R, et al.: Changing sexually transmitted infection screening protocol will result in improved case finding for trichomonas vaginalis among high-risk female populations. Sex Transm Dis 2011; 38: 398\u2013400","DOI":"10.1097\/OLQ.0b013e318203e3ce"},{"key":"10.3238\/arztebl.2016.0011_ref24","doi-asserted-by":"crossref","unstructured":"Kreuter A, Brockmeyer NH, Hochdorfer B, et al.: Clinical spectrum and virologic characteristics of anal intraepithelial neoplasia in HIV infection. J Am Acad Dermatol 2005; 52: 603\u20138","DOI":"10.1016\/j.jaad.2004.11.026"},{"key":"10.3238\/arztebl.2016.0011_ref25","unstructured":"Robert Koch-Institut: HIV-Diagnosen und AIDS-Erkrankungen in Deutschland. Epidemiologisches Bulletin 2015; 27."},{"key":"10.3238\/arztebl.2016.0011_ref26","doi-asserted-by":"crossref","unstructured":"Lohse N, Hansen AB, Pedersen G, et al.: Survival of persons with and without HIV infection in Denmark, 1995\u20132005. Ann Intern Med 2007; 146: 87\u201395","DOI":"10.7326\/0003-4819-146-2-200701160-00003"},{"key":"10.3238\/arztebl.2016.0011_ref27","doi-asserted-by":"crossref","unstructured":"May M, Gompels M, Delpech V, et al.: Impact of late diagnosis and treatment on life expectancy in people with HIV-1: UK Collaborative HIV Cohort (UK CHIC) Study. BMJ 2011; 343: d6016","DOI":"10.1136\/bmj.d6016"},{"key":"10.3238\/arztebl.2016.0011_ref28","doi-asserted-by":"crossref","unstructured":"Sabin CA: Do people with HIV infection have a normal life expectancy in the era of combination antiretroviral therapy? BMC Med 2013; 11: 251","DOI":"10.1186\/1741-7015-11-251"},{"key":"10.3238\/arztebl.2016.0011_ref29","doi-asserted-by":"crossref","unstructured":"Smith CJ, Ryom L, Weber R, et al.: Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaboration. Lancet 2014; 384: 241\u20138","DOI":"10.1016\/S0140-6736(14)60604-8"},{"key":"10.3238\/arztebl.2016.0011_ref30","doi-asserted-by":"crossref","unstructured":"Weber R, Ruppik M, Rickenbach M, et al.: Decreasing mortality and changing patterns of causes of death in the Swiss HIV Cohort Study. HIV Med 2013; 14: 195\u2013207 CrossRef","DOI":"10.1111\/j.1468-1293.2012.01051.x"},{"key":"10.3238\/arztebl.2016.0011_ref31","doi-asserted-by":"crossref","unstructured":"Bernstein KT, Marcus JL, Nieri G, Philip SS, Klausner JD: Rectal gonorrhea and chlamydia reinfection is associated with increased risk of HIV seroconversion. J Acquir Immune Defic Syndr 2010; 53: 537\u201343","DOI":"10.1097\/QAI.0b013e3181c3ef29"},{"key":"10.3238\/arztebl.2016.0011_ref32","doi-asserted-by":"crossref","unstructured":"Pathela P, Braunstein SL, Blank S, Schillinger JA: HIV incidence among men with and those without sexually transmitted rectal infections: estimates from matching against an HIV case registry. Clin Infect Dis 2013; 57: 1203\u20139","DOI":"10.1093\/cid\/cit437"},{"key":"10.3238\/arztebl.2016.0011_ref33","doi-asserted-by":"crossref","unstructured":"Patel P, Bush T, Mayer K, et al.: Routine brief risk-reduction counseling with biannual STD testing reduces STD incidence among HIV-infected men who have sex with men in care. Sex Transm Dis 2012; 39: 470\u20134","DOI":"10.1097\/OLQ.0b013e31824b3110"},{"key":"10.3238\/arztebl.2016.0011_ref34","unstructured":"Robert Koch-Institut: Syphilis in Deutschland 2012. Epidemiologisches Bulletin 2013; 44."},{"key":"10.3238\/arztebl.2016.0011_ref35","unstructured":"WHO: Guideline on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV. 2015. apps.who.int\/iris\/bitstream\/10665\/186275\/1\/9789241509565_eng.pdf?ua=1 (last accessed on 10 December 2015)."},{"key":"10.3238\/arztebl.2016.0011_ref36","doi-asserted-by":"crossref","unstructured":"Cohen MS, Chen YQ, McCauley M, et al.: Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med 2011; 365: 493\u2013505","DOI":"10.1056\/NEJMc1110588"},{"key":"10.3238\/arztebl.2016.0011_ref37","doi-asserted-by":"crossref","unstructured":"van de Laar TJ, Matthews GV, Prins M, Danta M: Acute hepatitis C in HIV-infected men who have sex with men: an emerging sexually transmitted infection. AIDS 2010; 24: 1799\u2013812","DOI":"10.1097\/QAD.0b013e32833c11a5"},{"key":"10.3238\/arztebl.2016.0011_ref38","doi-asserted-by":"crossref","unstructured":"Cornberg M, Manns MP: New kids on the block\u2014step by step to an ideal HCV therapy. Lancet 2015; 385: 1050\u20132","DOI":"10.1016\/S0140-6736(14)62008-0"},{"key":"10.3238\/arztebl.2016.0011_ref39","doi-asserted-by":"crossref","unstructured":"Kent CK, Chaw JK, Wong W, et al.: Prevalence of rectal, urethral, and pharyngeal chlamydia and gonorrhea detected in 2 clinical settings among men who have sex with men: San Francisco, California, 2003. Clin Infect Dis 2005; 41: 67\u201374","DOI":"10.1086\/430704"},{"key":"10.3238\/arztebl.2016.0011_ref40","unstructured":"Keikawus A, Baumgarten A, Behrens G, et al.: Deutsch-\u00d6sterreichische Leitlinien zur antiretroviralen Therapie der HIV-Infektion. In: AWMF, 2014. www.awmf.org\/uploads\/tx_szleitlinien\/055\u2013001l_Antiretrovirale_Therapie_der_HIV_Infektion__2014\u201305.pdf (last accessed on 10 December 2015)."},{"key":"10.3238\/arztebl.2016.0011_ref41","doi-asserted-by":"crossref","unstructured":"Aberg JA, Gallant JE, Ghanem KG, et al.: Primary care guidelines for the management of persons infected with HIV: 2013 update by the HIV medicine association of the infectious diseases Society of America. Clin Infect Dis 2014; 58: e1\u201334.","DOI":"10.1093\/cid\/cit665"},{"key":"10.3238\/arztebl.2016.0011_ref42","doi-asserted-by":"crossref","unstructured":"Workowski K, Berman, S, et al.: Sexually transmitted diseases treatment guidelines 2010. In: Centers for Disease Control and Prevention. MMWR 2010; 59: 1\u2013110.","DOI":"10.1093\/cid\/cir694"},{"key":"10.3238\/arztebl.2016.0011_ref43","doi-asserted-by":"crossref","unstructured":"Serwadda D, Gray RH, Sewankambo NK, et al.: Human immunodeficiency virus acquisition associated with genital ulcer disease and herpes simplex virus type 2 infection: a nested case-control study in Rakai, Uganda. J Infect Dis 2003; 188: 1492\u20137","DOI":"10.1086\/379333"},{"key":"10.3238\/arztebl.2016.0011_ref44","doi-asserted-by":"crossref","unstructured":"Freeman EE, Weiss HA, Glynn JR, Cross PL, Whitworth JA, Hayes RJ: Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies. AIDS 2006; 20: 73\u201383","DOI":"10.1097\/01.aids.0000198081.09337.a7"},{"key":"10.3238\/arztebl.2016.0011_ref45","doi-asserted-by":"crossref","unstructured":"Janata O, Reisinger E: Infektiologie. Aktuelle Aspekte 2001\/2002. Wien: Springer Verlag 2001.","DOI":"10.1007\/978-3-7091-6236-1"},{"key":"10.3238\/arztebl.2016.0011_ref46","unstructured":"Deutsche STI-Gesellschaft: STI-Leitfaden 2014. www.dstig.de\/literaturleitlinienlinks\/sti-leitfaden.html (last accessed on 10 December 2015)."},{"key":"10.3238\/arztebl.2016.0011_ref47","doi-asserted-by":"crossref","unstructured":"Li DK, Raebel MA, Cheetham TC, et al.: Genital herpes and its treatment in relation to preterm delivery. Am J Epidemiol 2014; 180: 1109\u201317","DOI":"10.1093\/aje\/kwu242"},{"key":"10.3238\/arztebl.2016.0011_ref48","doi-asserted-by":"crossref","unstructured":"Bradshaw CS, Tabrizi SN, Read TR, et al.: Etiologies of nongonococcal urethritis: bacteria, viruses, and the association with orogenital exposure. J Infect Dis 2006; 193: 336\u201345","DOI":"10.1086\/499434"},{"key":"10.3238\/arztebl.2016.0011_ref49","doi-asserted-by":"crossref","unstructured":"Anagrius C, Lore B, Jensen JS: Treatment of mycoplasma genitalium. Observations from a Swedish STD clinic. PLoS One 2013; 8: e61481","DOI":"10.1371\/journal.pone.0061481"},{"key":"10.3238\/arztebl.2016.0011_ref50","doi-asserted-by":"crossref","unstructured":"Marrazzo JM, Handsfield HH, Whittington WL: Predicting chlamydial and gonococcal cervical infection: implications for management of cervicitis. Obstet Gynecol 2002; 100: 579\u201384","DOI":"10.1097\/00006250-200209000-00029"},{"key":"10.3238\/arztebl.2016.0011_ref51","doi-asserted-by":"crossref","unstructured":"Moodley D, Moodley P, Sebitloane M, et al.: High prevalence and incidence of asymptomatic sexually transmitted infections during pregnancy and postdelivery in KwaZulu Natal, South Africa. Sex Transm Dis 2015; 42: 43\u20137","DOI":"10.1097\/OLQ.0000000000000219"},{"key":"10.3238\/arztebl.2016.0011_ref52","doi-asserted-by":"crossref","unstructured":"Kissinger P, Adamski A: Trichomoniasis and HIV interactions: a review. Sex Transm Infect 2013; 89: 426\u201333","DOI":"10.1136\/sextrans-2012-051005"},{"key":"10.3238\/arztebl.2016.0011_ref53","doi-asserted-by":"crossref","unstructured":"Schwebke JR, Hobbs MM, Taylor SN, et al.: Molecular testing for trichomonas vaginalis in women: results from a prospective U.S. clinical trial. J Clin Microbiol 2011; 49: 4106\u201311","DOI":"10.1128\/JCM.01291-11"},{"key":"10.3238\/arztebl.2016.0011_ref54","doi-asserted-by":"crossref","unstructured":"Ramqvist T, Grun N, Dalianis T: Human papillomavirus and tonsillar and base of tongue cancer. Viruses 2015; 7: 1332\u201343 MEDLINE","DOI":"10.3390\/v7031332"},{"key":"10.3238\/arztebl.2016.0011_ref55","doi-asserted-by":"crossref","unstructured":"Nielson CM, Harris RB, Dunne EF, et al.: Risk factors for anogenital human papillomavirus infection in men. J Infect Dis 2007; 196: 1137\u201345","DOI":"10.1086\/521632"},{"key":"10.3238\/arztebl.2016.0011_ref56","unstructured":"Brockmeyer N, Degen O, Eldering G, et al.: Anale Dysplasien und Analkarzinome bei HIV-Infizierten: Pr\u00e4vention, Diagnostik, Therapie. In: AWMF; 2014."},{"key":"10.3238\/arztebl.2016.0011_ref57","doi-asserted-by":"crossref","unstructured":"Samji H, Cescon A, Hogg RS, et al.: Closing the gap: increases in life expectancy among treated HIV-positive individuals in the United States and Canada. PLoS One 2013; 8: e81355.","DOI":"10.1371\/journal.pone.0081355"},{"key":"10.3238\/arztebl.2016.0011_ref58","doi-asserted-by":"crossref","unstructured":"Hollingsworth TD, Anderson RM, Fraser C: HIV-1 transmission, by stage of infection. J Infect Dis 2008; 198: 687\u201393","DOI":"10.1086\/590501"},{"key":"10.3238\/arztebl.2016.0011_ref59","doi-asserted-by":"crossref","unstructured":"Fiebig EW, Wright DJ, Rawal BD, et al.: Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection. AIDS 2003; 17: 1871\u20139","DOI":"10.1097\/00002030-200309050-00005"},{"key":"10.3238\/arztebl.2016.0011_ref60","doi-asserted-by":"crossref","unstructured":"Vernazza P, Hirschel, B, Bernasconi, E, Flepp, M: HIV-infizierte Menschen ohne andere STD sind unter wirksamer antiretroviraler Therapie sexuell nich infekti\u00f6s. Schweizerische \u00c4rztezeitung 2008; 89: 165\u2013169.","DOI":"10.4414\/saez.2008.13252"},{"key":"10.3238\/arztebl.2016.0011_ref61","doi-asserted-by":"crossref","unstructured":"Patel P, Borkowf CB, Brooks JT, Lasry A, Lansky A, Mermin J: Estimating per-act HIV transmission risk: a systematic review. AIDS 2014; 28: 1509\u201319","DOI":"10.1097\/QAD.0000000000000298"},{"key":"10.3238\/arztebl.2016.0011_ref62","unstructured":"Rodger A, Bruun T, Weait M, et al.: HIV-transmission risk through condomless sex if the HIV positive partner on suppressiv ART: PARTNER Study. In: CROI. Boston; 2014."},{"key":"10.3238\/arztebl.2016.0011_ref63","unstructured":"Department of Health and Human Services: Panel on antiretroviral guidelines for adults and adolescents. Guidelines for the use of an-tiretroviral agents in HIV-1-infected adults and adolescents. www.aidsinfo.nih.gov\/ContentFiles\/AdultandAdolescentGL.pdf. (last accessed on 10 December 2015)"},{"key":"10.3238\/arztebl.2016.0011_ref64","doi-asserted-by":"crossref","unstructured":"Urbanus AT, van de Laar TJ, Stolte IG, et al.: Hepatitis C virus infections among HIV-infected men who have sex with men: an expanding epidemic. AIDS 2009; 23: F1\u20137.","DOI":"10.1097\/QAD.0b013e32832e5631"},{"key":"10.3238\/arztebl.2016.0011_ref65","doi-asserted-by":"crossref","unstructured":"European Association for Study of Liver: EASL Clinical Practice Guidelines: management of hepatitis C virus infection. J Hepatol 2014; 60: 392\u2013420","DOI":"10.1016\/j.jhep.2013.11.003"},{"key":"10.3238\/arztebl.2016.0011_ref66","unstructured":"Sarrazin C, Berg T, Buggisch P, et al.: Aktuelle Empfehlung zur Therapie der chronischen Hepatitis C Addendum vom 18.\u00a02.\u00a02015 zur S3-Leitlinie 021\/012. (Last accessed on 10 December 2015)."},{"key":"10.3238\/arztebl.2016.0011_ref67","doi-asserted-by":"crossref","unstructured":"Wedemeyer H. [Treatment of hepatitis C: what is known?]. Internist 2014; 55: 1419\u201326","DOI":"10.1007\/s00108-014-3554-2"}],"container-title":["Deutsches \u00c4rzteblatt international"],"original-title":[],"link":[{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.2016.0011","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,6]],"date-time":"2021-12-06T13:09:35Z","timestamp":1638796175000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.2016.0011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,11]]},"references-count":67,"URL":"https:\/\/doi.org\/10.3238\/arztebl.2016.0011","relation":{},"ISSN":["1866-0452"],"issn-type":[{"value":"1866-0452","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,11]]}}}